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The present study investigated the role of H2S in skin wound healing in rats. Dermal 
wound healing is a complex phenomenon involving inflammation, re-epithelialization, 
granulation tissue and tissue remodeling. Square wounds (15 mm x 15 mm) were 
made on the dorsal surface of the rats; wounded skin exhibited enhanced H2S 
synthesis enzyme activity, similarly elevated H2S synthesizing activity was detected 
in liver. Pretreatment with DL-propargylglycine (PAG), an inhibitor of 
cystathionine-γ-lyase (synthesize H2S from L-cysteine), significantly and 
dose-dependently reduced H2S synthesizing activity in both skin and liver of the rats, 
and more importantly shortened the time for wound repair. Compared to healthy skin 
samples, myeloperoxidase (MPO) enzyme activity (indicator of inflammation) 
increased in wounded skin, and PAG administration significantly reduced MPO 
activity in wounded skin compared to non-treated animals. Histological analysis also 
revealed that aggregated fibroblast-like cells were noted in rats pretreated with PAG. 
The inhibition of H2S synthesizing activity effectively reduced skin inflammation and 
shortened healing time in these animals thereby suggesting a role for H2S in wound 
healing. 
 
To examine directly the possible pro-inflammatory effect of H2S, rats was pretreated 
with S-diclofenac (H2S donor drug, 100μmol/kg) and the pretreatment induced in a 
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 significant prolonged wound repair process. PAG was also incorporated into 
polyethylene glycol based hydrogel and in-vivo released from the matrix along with 
the degradation of wound dressing gel. The wound healing efficacy of the 
PAG-incorporated hydrogel dressing was evaluated using the full-thickness wounds in 
the same rat model. Data obtained in this study showed that PAG in hydrogel 
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Production, metabolism and functional targets of 
nitric oxide (NO) [1] 
 
 




The biosynthesis of Nitric Oxide Production, 
metabolism and functional targets of nitric oxide 
(NO) [1] 
 
The biosynthesis, mechanism of action and 
principal biological effects of hydrogen sulfide (H2S) 
 
 
Fig 2.3 Chemical Structure of S- Diclofenac 
(2-[(2,6-dichlorophenyl)amino] benzeneacetic 





































































































































































Time and dose dependent effects of PAG 
pretreatment on H2S synthesizing activity in skin 
tissue. Skin H2S synthesizing activities in wounded 
animals with low and high doses of drug treatment 
are shown. Initial: healthy animal sample without 
wounding; Control: rats with vehicle pretreatment 
after wounding; GrpB: rats pretreated with 10mg/kg 
weight PAG 2 h before wounding. GrpC: rats 
pretreated with 100mg/kg weight PAG 2 h before 
wounding. Results are shown as mean±SE, n=6, 
+P<0.05 over null animal skin samples, *P<0.05 over 
vehicle administrated control]  
 
 
Time- and dose-dependent effects of PAG 
pretreatment on H2S synthesizing activity of liver 
tissue is shown as positive controls. Initial: healthy 
animal sample without wounding; Control: rats with 
vehicle pretreatment after wounding; GrpB: rats 
pretreated with 10mg/kg weight PAG 2 h before 
wounding. GrpC: rats pretreated with 100mg/kg 
weight PAG 2 h before wounding. Results are shown 
as mean±SE, n=6, +P<0.05 over null animal skin 
samples, *P<0.05 over vehicle administrated control]  
 
 
Time dependent effects of MPO activity in skin 
wound healing with vehicle treatment. Assume 100% 
MPO activity before wounding, Results are shown as 
mean±SE, n=6, *P<0.05 c.f. Null control. MPO 
activity was measured on day 5 and day 10. 
 
 
MPO activity with different doses of PAG 
administration in wound healing on day 5 after 
wounding. [Null: healthy animal sample without 
wounding; Control: rats with vehicle pretreatment 
after wounding; GrpB: rats pretreated with 10mg/kg 
weight PAG 2 h before wounding. GrpC: rats 
pretreated with 100mg/kg weight PAG 2 h before 
wounding. Results are shown as mean±SE, n=6, 
+P<0.05 over healthy animal skin samples, *P<0.05 









































































































Wound contractions plotted as the fraction of 
original area after wounding. The original 
wounded area at day 0 is defined as 100 percent 
original area, the areas at day 3, 6 and 9 are 
calculated as the percentage of the original area 
for each group of rats. The data of 6th day 
suggests the largest difference among groups 
with different dose pretreatment [Initial: 100% 
original area; Control: rats with vehicle 
pretreatment 2 h before wounding; GrpB: rats 
pretreated with 10mg/kg weight PAG 2 h before 
wounding. GrpC: rats pretreated with 100mg/kg 
weight PAG 2 h before wounding, n=6, +P<0.05, 
c.f vehicle administrated controls]  
 
 
Hematoxylin and eosin stained sections of skin 
samples from control, GrpB & GrpC. [A] and [B] 
show the cutaneous cell structure of the rats from 
control group at day 5 and day 10 respectively [C] 
and [D] show the sections from GrpB animals at 
day 5 and day 10 respectively; [E] and [F] 
showed the pictures from GrpC animals at day 5 
and day 10 respectively. [G] & [H] were in large 
view of the 400 pixels x 400 pixels squares taken 
from [E] & [F]. [Control: animal skin samples with 
vehicle treatment after wounding; GrpB: rats with 
10mg/kg weight PAG pretreated 2 h before 
wounding. GrpC: rats with 100mg/kg weight PAG 
pretreated 2 h before wounding] 
 
 
The numbers of fibroblast-like cells from each 
group of animals per 400 pixels x 400 pixels 
square were counted by a haemacytometer. Null: 
null animal sample without wounding; Control: 
rats with vehicle treatment; GrpB: rats with 
10mg/kg weight PAG pretreated 2 h before 
wounding. GrpC: rats with 100mg/kg weight PAG 
pretreated 2 h before wounding. Results are 
mean±SE, [n=6, +P<0.05 over null animal skin 



















































Wound contractions plotted as the fraction of 
original area after wounding. The original 
wounded area at day 0 is defined as 100 
percent original area; the areas at day 3, 6 
and9 are calculated as the percentage of the 
original area for each group of rats. The data of 
6th day suggests the largest difference among 
groups with different dose pretreatment [Initial: 
100% original area; Control: rats with vehicle 
pretreatment 2 h before wounding; Ac-Na: rats 
pretreated with 100mg/kg Diclofenac Sodium 2 
h before wounding. Ac-S: rats pretreated with 
100mg/kg S-Diclofenac 2 h before wounding, 
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Recent years, novel roles for gases such as nitric oxide (NO), carbon monoxide (CO) 
and hydrogen sulfide (H2S) have been identified in physiology and in disease. Nitric 
oxide was previously considered to be no more than a potentially toxic chemical, but 
now has been firstly established as a diffusible, universal messenger able to mediate 
cell-cell communication through out the body [1]. Endogenous NO is synthesized 
from the amino acid, L-arginine, by a family of enzymes referred to as nitric oxide 
synthase (NOS).  
 
Fig1.1. Production, metabolism and functional targets of nitric oxide (NO). [1] 
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Constitutive and inducible NO production regulates many essential functions such as 
maintaining background vasodilatation in small arteries and arterioles, regulation of 
microvascular and epithelial permeability. NO’s role as a neurotransmitter in the CNS 
and a neurally-mediated vasodilator in the pulmonary circulation was also suggested 
[1]. Endogenous NO produced in activated murine macrophages by NO synthesizing 
enzymes is important in immune response, while nitric oxide also contributes to the 
acute inflammatory response mediated by endotoxin, cytokines or physicochemical 
stress. [2] In the gastrointestinal tract, endocrine system, pregnancy, NO has also been 
widely studied. [3] To conclude, nitric oxide is an important inter- and intracellular 
gas mediator, governing a range of physiological functions in animals and humans, 
from controlling smooth muscle tone in the cardiovascular, gastrointestinal, 
respiratory and genitourinary systems, to neurotransmission and a role in immune 
function and inflammation. 
 
The body appears to use at least one other, highly related gas in a signaling function- 
carbon monoxide (CO). CO is produced together with ferrous iron and bilirubin by 
the action of heme oxygenase, in collaboration with cytochrome P450 reductase and 
biliverdin reductase [4]. Exogenous CO modulates the release of hypothalamic 
hormones [5，6], regulates vascular tone [7], and is a protective factor in hypoxia [8]. 
In the intestine, CO relaxes the opossum internal anus sphincter [9] and 
hyperpolarizes isolated human and canine jejunal circular smooth muscle cells [10]. 
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Besides NO and CO, hydrogen sulfide (H2S) has also been suggested as an 
endogenous gaseous mediator with a number of potentially important physiological 
and pathophysiological roles within the body. [11] 
 
 
z Fig.1.2. The endogenous biosynthesis of hydrogen sulfide (H2S).[11] 
 
In the body, cystathionine-γ-lyase (CSE) and cystathionine-β-synthetase (CBS) 
catalyze the production of H2S from L-cysteine. H2S is broken down either chemically 
or by sequestration with macromolecules such as haemoglobin or glutathione. Major 
biological effects of endogenous released H2S include smooth muscle relaxation in the 
cardiovascular system and promotion of neuronal long-term potentiation (LTP) in 
CNS. [11] 
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The pro-inflammatory effect of H2S in vivo has been suggested in inflammatory 
diseases like endotoxic [12] and septic shock [13], oedema formation [14] and 
neurogenic inflammation [15]. So far, most of the evidence supporting the 
pro-inflammatory role of H2S has come from animal models of endotoxic or septic 
shock. Elevated tissue H2S formation was first noted in a caecal ligation and puncture 
model of septic shock in the rat by Hui et al. [16]. In lipopolysaccharide-induced 
endotoxic shock, H2S formation in plasma and several tissues like liver, kidney was 
significant up-regulated for mice and rats. [12] Consequently inhibiting H2S 
biosynthesis can be beneficial in these animal models of shock with ameliorated lung 
and liver damage confirmed by histological evidences, and represents a novel 
approach to potential drug discovery. [13] That endogenous H2S was found to 
participate in hindpaw swelling was also suggested in animals using a standard test for 
oedema formation (carrageenan-induced hindpaw swelling) [14]. Several reports 
suggested that H2S simulated sensory nerve endings in neurogenic inflammation, by 
releasing endogenous tachykinins such as substance P (SP), calcitonin gene-related 
peptide and neurokinin A.[17] Recent work also demonstrated that inhibition of H2S 
generation contributes to gastric injury caused by non-steroidal anti-inflammatory 
drugs (NSAIDs). Exposure to NSAIDs also significantly reduced gastric H2S 
formation and CSE expression and activity. [18] 
 
To the best of our knowledge, the part played by H2S in the complex pattern of events 
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which underlies wound healing has not previously been described. The aim of the 
present study is therefore to identify the possible roles of H2S in wound healing. 
 
 
1.2 Reasons for the study 
 
Hydrogen sulphide (H2S) and NO, both play numbers of important physiological and 
pathophysiological roles within the body. Both gaseous mediators are synthesized in 
blood vessels. [19]   
 
Functionally, NO is an important regulator of vascular tone and its over- or 
under-production has been linked to a variety of cardiovascular diseases. [20] NO has 
been demonstrated an important role in inflammation and wound healing models, 
experiments showed that NOS (nitric oxide synthase) activity was up-regulated during 
wound healing and that the highest NOS activity occurs during the early phase of 
wound healing [21]. With a polyvinyl alcohol sponge model in rats, a progressive 
accumulation of nitrate/nitrite (both products of NO) in wound fluid can be 
demonstrated; suggesting sustained NO synthesis [22]. With the development of the 
inducible NOS isoform–specific antibodies and primers for transcriptional and 
translational analysis, it has been demonstrated that iNOS expression is highest in the 
early phase after acute inflammation. Reverse-transcriptase polymerase chain reaction 
(RT-PCR) and northern blotting detect iNOS during the first 5 days in rat models of 
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wound healing. [21, 22]  
 
Nowadays, the physiological significance of H2S is not yet as clear as NO, but like 
NO, it exhibits vasodilator [23] and pro-apoptotic activity [11] in vascular smooth 
muscle. Work in this laboratory has confirmed the pro-inflammatory role of H2S in 
LPS-induced endotoxic shock, cecal ligation as well as other inflammation models 
[25]. Since NO and H2S share many similar biological characteristics, some scientists 
suggested the possibility of some form of “cross talk” between vascular NO and H2S, 
but the precise nature of such an interaction has not yet been defined. [26] NO 
exhibited potent pro-inflammatory activity in wound repair. [21] However, the role of 
H2S in wound healing process has not been addressed previously. Based on the 
information above, we hypothesized that H2S may also play a similar role to NO in 
wound healing in the rat. 
 
1.3 Thesis Overview and Scope 
 
The aim of the work presented in this thesis is to determine the role of H2S in skin 
wound healing and the effect of PAG pretreatment. Accordingly, the main objectives 
of this project are as follow: 
 
(1) Investigate the potential pro-inflammatory effect of H2S in animal tissue and skin 
after a standard skin wounding procedure. 
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(2) Investigate the inflammation and wound recovery after PAG administration. 
 
(3) Compare the H2S releasing profiles and outcomes of S-diclofenac administration 
and PAG incorporated hydrogel dressing on wound healing. 
 
In Chapter 2, a detailed literature review is presented, which includes an analysis of 
the function of the newly discovered gas mediator, H2S, in the cardiovascular system; 
inflammation in wound healing; DL-propargylglycine (PAG) and S-diclofenac 
(Ac-S)’s properties and effects as the inhibitor of H2S synthesizing and H2S donor; 
assembly of hydrogel in wound dressing and the study of the PAG-incorporated 
hydrogel. The details of materials and methods for this project are contained in 
Chapter 3. Chapter 4 describes the effects of PAG (cystathionine-γ-lyase inhibitor) in 
skin wound healing, which significantly reduced the half time for healing and played 
an anti-inflammatory role. Chapter 5 presents the histological pictures and discussion 
of skin wound repair after PAG administration. Chapter 6 discusses the effect of a H2S 
donor drug (S-diclofenac) in wound healing, comparing with PAG discussed above; 
describes a novel design for PAG incorporated hydrogel wound dressing and 
discusses the application of PAG control-released hydrogel in wound care. Finally, a 
summary of all the research topics in this thesis is provided in the Chapter 7.  
 
1.4 List of Publications 
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1. Lingxu Hu BSc, 2Shabbir M. Moochhala PhD, 2Lu Jia MD, PhD, 1Philip K. Moore 
PhD A novel role for hydrogen sulfide (H2S) in wound healing in the rat  Wound 
Repair and Regeneration [in progress] 
 
2．Lingxu Hu, Philip K, Moore: The novel role of hydrogen sulfide in wound healing 
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Chapter 2  
Literature Review 
 
2.1 The discovery of NO and H2S as Gas Mediators  
  
The ability of mammalian cells to synthesize an endothelium-derived relaxant factor 
(EDRF) was first demonstrated in 1980. In 1987, it was shown that the actions of 
EDRF and nitric oxide (NO) were substantially similar [1], and during the subsequent 
decade, progress in understanding the biological roles of NO has been remarkable. 
Thus, NO was regarded initially only as an atmospheric pollutant present in vehicle 
exhaust emissions and cigarette smoke. In the last decade, NO has been identified as 
an (almost) ubiquitous biological mediator, implicated in the pathogenesis of diseases 
as diverse as hypertension, asthma, septic shock and dementia; and as a potential 
marker of clinical diseases, that may prove amenable to therapeutic manipulation. 
[2-3] 
 
Nitric oxide is synthesized from the terminal guanidine nitrogen of L-arginine, which 
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z Fig. 2.1 the biosynthesis of Nitric oxide [2]  
 
Similar to cytochrome P450, NOS are complex haemoproteins containing both 
oxidative and reductive domains. The production of NO requires the participation of 
oxygen (O2), nicotinamide adenine dinucleotide phosphate (NADPH) and a number of 
cofactors to cooperate, such as tightly-bound flavoprotein and tetrahydrobiopterin. So 
far scientists has identified three major isoforms of NOS: neuronal NOS (nNOS or 
type 1), inducible NOS (iNOS or type 2), and endothelial NOS (eNOS or type 3). 
Type 1&3 are expressed constitutively and are both termed constitutive nitric oxide 
synthase (cNOS); type 2 is a macrophage-derived form induced by endotoxin and 
inflammatory mediators, such as cytokines [19, 20]. The genes for these isoforms 
have been localized to chromosomes 7 (eNOS), 12 (nNOS) and 17 (iNOS) [23]. 
Mechanism studies revealed that the reductive domain of NOS provides reducing 
equivalents from NADPH to the haem domain, where NO was produced. [11] The 
NOS isoforms are activated via second messengers, such as calcium. In the presence 
of appropriate substrates, these enzymes catalyze the formation of NO, which is either 
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inactivated by its reaction with haemoglobin or albumin, acts as a biological mediator 
via guanylate cyclase, or forms toxic radical derivatives through its reaction with 
reactive oxygen species (ROS). [25] 
 
Recently, another similar endogenous gaseous mediator, hydrogen sulphide (H2S) was 
discovered to be a novel gas mediator within the body other than nitric oxide. Within 
the cardiovascular system and central nervous system, H2S is synthesized from 
L-cysteine by cystathionine-γ-lyase (CSE) or cystathionine-β-synthetase (CBS). 
[27, 28] Both NO and H2S can be synthesized in blood vessels [27]. Functionally, NO 
is an important regulator of vascular tone and its up- or down-regulation has been 
linked to a variety of cardiovascular diseases. In contrast, the physiological 
significance of H2S is not yet as clear as NO, but it exhibits the same vasodilator 
effect with NO [29] and pro-apoptotic activity in vascular smooth muscle [30]. 
Elevated concentrations of H2S also occur in animal models of both septic [30] and 
haemorrhagic [12] shock, hypertension. [14]  
 
‘Cross talk’ may occur between the two gases at other levels, For example, the NO 
donor, sodium nitroprusside (SNP) up-regulates H2S production in rat vascular tissues 
by augmenting expression of CSE or CBS, which suggest a possible interaction of 
these gases at the expression level of their synthesizing enzymes. At the level of 
vascular smooth muscle cells, for example, H2S has been reported to either enhance 
[33, 34] or to attenuate [12] the relaxant effect of NO in the rat aorta. In addition, H2S 
                                           - 22 - 
                                                             Chapter 2 Literature Review 
is a potent scavenger of peroxynitrite, which perhaps indicates a chemical interplay 
between H2S and NO/ROS. [16, 36] 
 
More research has been done on the H2S in the last few years. Figure 2.2 shows us the 




z Fig. 2.2 The biosynthesis, mechanism of action and principal biological effects of 
hydrogen sulfide (H2S). [11] 
 
Cystathionine-γ-lyase or cystathionine-β-synthase catalyze the production of H2S 
from L-cysteine in the cardiovascular system and in the CNS. Major biological effects 
of released H2S include smooth muscle relaxation and promotion of neuronal 
long-term potentiation (LTP). In the cardiovascular system, due to some unclear 
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mechanisms H2S is released, presumably by free diffusion, to act on the target cell by 
activating K+ATP channels directly to cause hyperpolarization (neurons) or relaxation 
(smooth muscle cells). In brain, an influx of Ca2+, perhaps triggered by the activation 
of NMDA receptors by glutamate or via other channels, thereby activates CBS via 
binding to calmodulin (CaM). H2S is broken down either chemically or by 
sequestration with macromolecules such as haemoglobin or glutathione. H2S released 
by donor cell may acts on a target cell or the donor cell itself. [11] 
 
 
2.2 Morphology and physiology in skin wound healing  
 
In dermatology, skin is an organ made up of layers of cells (e.g. epithelial cells) that 
protect underlying muscles and organs. Interplaying with surroundings, it plays an 
important role in protecting against outside pathogens, insulation, temperature 
regulation, sensation and vitamin D and B biosynthesis. The skin is also regarded as 
"the largest organ of the human body". This applies to exterior surface area as well as 
weight, as it weighs more than any single internal organ, accounting for about 15 
percent of body weight.  
 
Skin wound healing, or wound repair, is the body's natural response to the wound by 
regenerating new layers of skin. When an individual is wounded, a series of events 
take place immediately to repair the wound in a predictable manner. Generally the 
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wound healing can be categorized into the inflammatory phase, re-epithelialization 
phase and tissue remodeling phase and they overlap each other.[37, 38] Immediately 
after wounding the inflammatory phase occurred, bacteria and debris are phagocytized 
and removed, cytokines are released and cause the migration and division of cells. 
The second re-epithelialization phase is characterized by angiogenesis, fibroplasia, 
granulation tissue formation, epithelialization, and wound contraction. In angiogenesis, 
new blood vessels grow from endothelial cells. In fibroplasia and granulation tissue 
formation, fibroblasts grow and form a new, provisional extracellular matrix (ECM) 
by collagen and fibronectin deposition. In epithelialization, epithelial cells crawl 
across the wound bed to cover the wound. In contraction, the wound is made smaller 
by the action of myofibroblasts, which start from the wound edges and move inward 
using a mechanism similar to that in smooth muscle cells. In the final remodeling 
phase, collagen is remodeled and realigned along tension lines and cells that are no 
longer needed are removed by apoptosis. [39] 
 
Normal healing is a finely orchestrated and overlapping sequence of events like 
coagulation, inflammation, fibroplasia and remodeling. [39] Cytokines are the 
messengers that mediate all the events in the healing process from the moment of 
injury until the final close of the tissue. The cytokines start from the coagulation 
process and throughout the inflammatory phase, platelet-derived growth factor 
(PDGF), transforming growth factor-β (TGF-β), epidermal growth factor (EGF), and 
basic fibroblast growth factor (bFGF) are major factors in repair. [40] The rate of 
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matrix metabolism is increased during the repair process.  
 
Wound contraction is the process wherein wound edges are drawn together by inward 
movement of surrounding tissue. In contrast, a contracture is the pathologic result of 
excessive contraction. Briefly, this process appears to be performed by specialized 
fibroblast cells that contain smooth muscle actin and have been termed myofibroblasts. 
The extracellular matrix is also considered to be involved in regulating the process of 
contraction.  
 
Clinically, both local and systematic factors can affect the healing process. These 
include tissue hypoxia, denervation, hematoma, infection, irradiation and mechanical 
forces. Wound dressing can reduce the pains and accelerate the wound healing process, 
especially the newly emerged “hydrogel dressing” which can maintain a moisture 
condition in the wound area. [38] 
 
2.3 Inflammation phase in wound healing 
 
Trauma comes in many forms and degrees of severity. In general, the greater the 
injury-induced volume of tissue loss and healing burden, the greater the amount of 
resources needed to repair and close the wounds. 
  
Initially after bleeding was stopped, platelets release a number of substances that 
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contribute to the intensity of the inflammatory response (e.g. platelet derived growth 
factor PDGF, prostacyclin PGI2). These metabolites (e.g. leukotrienes) are soluble 
factors which advance tissue repair. Much remains to be investigated regarding this 
series of reactions mediated by any one of these factors, and they remain a subject of 
interest to the basic scientist, as well as the clinician seeking tools to better control the 
wound healing process. [41] The cytokines can be considered as wound hormones 
because they are first synthesized, then released, and can affect cell functions distant 
from their site of secretion. These compounds can be classified broadly on the basis of 
the cells targeted for their actions. Paracrine cytokines (cytokines e.g. IL-1 and IL-8) 
act upon cells those are distant from the cells that produce them. Autocrine cytokines 
are secreted from the cell and their action is back to that donor cell. Intracrine 
cytokines (e.g. granulocyte macrophage-colony stimulating factor, GM-CSF) remain 
inside the cell of production and exert their effects upon that cell without being 
secreted. [42] 
 
The initial inflammatory cell population to enter the wound site is the neutrophil, 
whose major functions are to destroy microbes and release chemoattractants. 
Neutrophils leave the microvasculature, migrating between the altered endothelial 
cells. These leucocytes function primarily as a first line of defense, working to both 
phagocytize and kill microorganisms invading through the breached integument. 
Neutrophils are often found between surviving tissues and necrotic tissues and 
necrotic tissues. In open wounds, they reveal the path that will be followed by the 
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migrating epidermal cells which re-epithelialize the surface of the wound. 
 
In some experimental animal wound healing studies, it has been shown that blocking 
the invasion of neutrophils into the wound site does not alter the outcome of the repair 
process. [43] However, in human chronic granulomatous disease where an absence of 
the enzyme NADPH-oxidase occurs, the intracellular killing of bacteria and fungi 
within neutrophils is comprised. This inability to kill microbes results in chronic 
infections which retard the repair process, leading to decreased survival of the 
affected host. [44] 
 
Within 24 h after the invasion of neutrophils, a second wave of inflammatory cells-the 
monocytes-invade the wound site. Upon exiting the vasculature and entering the 
wound site, the monocyte becomes a tissue macrophage which has numerous 
activities that are critical for the continuation and progression of the repair process. 
Tissue macrophages have the capacity to divide within the wound site, and are 
responsible for eradicating microbes and clearing non-viable tissue, by ingesting and 
breaking down of necrotic debris. Another function of the macrophages is the release 
of growth factors which facilitate the migration of synthetic cells into wound sites and 
the production of a new connective tissue matrix.  
 
Macrophages synthesize and release growth factors which are important for the 
initiation of the next phase of the repair process, the re-epithelialization phase. The 
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successful progression through this phase is vital to the subsequent repair process. 
However, it should be remembered that control of inflammation is important since 
both of too much or too little response is detrimental to the repair process. [45] 
 
 
2.4 Diclofenac sodium and S-diclofenac 
 
As one member of the group of non-steroidal anti-inflammatory drugs (NSAIDs), 
diclofenac is an anti-inflammatory benzene acetic acid derivative that has been used 
to treat acute pain and swelling associated with rheumatic disorders since 1974. [46] It 
is used mainly as sodium or potassium salt with 75 mg to 150 mg given to patients 
daily in divided doses. [47] The efficacy of NSAIDs in the postoperative context is 
supported by numerous clinical studies and systematic reviews. [48] It is known that 
this drug inhibits biosynthesis of the prostaglandin both in vivo and in vitro; the drug 
has also shown only a slightly adverse effect on the stomach and intestines. [49] 
 
Diclofenac is usually available in two different formulations, diclofenac sodium, 
which was used as control in our experiments presented later and diclofenac 
potassium. Diclofenac potassium is formulated to be released and absorbed in the 
stomach. Diclofenac sodium, usually distributed in enteric-coated tablets, resists 
dissolution in low pH gastric environments, releasing instead in the duodenum [50]. 
The sodium and potassium formulations present different hypothetical advantages; the 
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immediate- release potassium formulation might provide pain relief more quickly [51]; 
whereas the delayed-release formulation might minimize gastric exposure 
theoretically minimizing the risk of adverse gastrointestinal events (this is unlikely as 
NSAID-related gastrointestinal adverse effects are more closely linked with systemic 
overall concentration). The clinical bearing of these differences has yet to be 
established.  
 
Like other NSAIDs, diclofenac acts by inhibiting cyclooxygenase (COX) isoforms 
that mediate the body’s production of the prostaglandins implicated in pain and 
inflammation. NSAIDs are known to cause serious upper gastrointestinal adverse 
effects, renal, hepatic toxicity, and fluid retention and extended bleeding time. 
Research has also implicated diclofenac in haematological abnormalities [47]. It is 
likely that the majority experiencing severe adverse effects will be elderly chronic 
pain sufferer taking maximal doses over an extended period of time. Both dose and 
age have been identified as risk factors along with sex, past ulcer history and 
co-medication with anti-coagulants or corticosteroids [52-57].  
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Fig 2.3 Chemical Structure of S- Diclofenac (2-[(2,6-dichlorophenyl)amino] 
benzeneacetic acid4-(3H-1,2,dithiole-3-thione-5-yl )- -phenyl ester) 
 
2-[(2,6-dichlorophenyl)amino]benzeneacetic acid4-(3H-1,2,dithiole-3-thione-5-yl )- 
-phenyl ester (a H2S releasing ester form of diclofenac, S-diclofenac ) is a newly 
synthesized drug candidate, in which a part of the drug is modified by adding a H2S 
releasing factor. [Fig 2.3] S-diclofenac releases H2S slowly after administration. (Li et 
al 2007, in press) This drug was developed and presented to us by CTG Pharma 
(Milan, Italy). 
 
2.5 Hydrogel dressing in wound healing 
 
The ideal wound dressing should provide an environment at the surface of the wound 
in which healing may take place at the maximum rate of wound contraction consistent 
with an acceptable appearance. [56] 
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For centuries, man has developed various substances to stop bleeding, ease pain, or 
provide protection for newly formed wounds. Many of these dressings were just 
simple absorbents that remove exudates and produce a dry environment for wound, 
which was believed to be beneficial for wound healing. It was not until 1960s this 
view was challenged by George Winter and his work demonstrated the advantages of 
moist wound healing compared to a dry wound. [57] His work stimulated many 
sophisticated new dressings and the idea of maintaining moisture conditions during 
wound healing has became more general and has still been making progress today. 
[58] 
 
It is currently believed that in order for healing to proceed at the optimum rate, a 
wound should be: 
 
z Moist with exudates but not macerated; 
z Free of clinical infections and excessive slough; 
z Free of toxic chemicals, particles, or fibres released by the dressing 
z At the optimum temperature 
z Undisturbed by frequent or unnecessary dressing changes; 
z At the correct pH 
 
The concept of hydrogel dressing was realized since 1960. The potential value of 
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hydrogels in medicine was first recognized by Wichterle and Lim [59], who described 
a family of products based upon glycol methacrylates. A hydrogel is formed when 
insoluble polymers with hydrophilic sites bind or react chemically together to form 
pores that absorb or otherwise take up significant volumes of water. The polymers 
themselves may be prepared from one or more kinds of polymers. Recent finding has 
shown that moist conditions created by hydrogel help accelerate the wound healing 
compared to dry conditions [60].  
 
The hydrophilic polyethylene glycol (PEG) polymers have many advantageous 
characteristics over other polymers in biomedical research and provide a good 
candidate for wound hydrogel dressing. PEG, with molecular weight exceeding 20 
kDa, is a hydrolytically non-degradable polymer with excellent solubility in water and 
many different organic solvents. [61-63] Accordingly, PEG-based polymers can be 
utilized in many different synthetic strategies. Since PEG itself is non-degradable by 
simple hydrolysis and undergoes only limited metabolism in the body, the whole 
polymer chains are eliminated through the kidneys (<30 kDa) or eventually through 
the liver (>30 kDa). [64] But when PEG is copolymerized or covalently linked to 
other polymers, careful material design must be done to ensure that all adjacent 
polymer chains are degradable and efficiently release the low molecular weight PEG 
blocks. 
 
Besides its excellent water solubility and biocompatibility, PEG easily forms crystals 
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after drying. Thus, when PEG is utilized in blends or copolymers, PEG crystals and 
endothermic melting signals can be easily detected. [65, 66] The melting point of the 
PEG derivatives is relevant to the molecular weight of the chain. For example, PEG 
400 is a viscous liquid at room temperature, while PEG 2000 and PEG 6000 are solid 
materials with melting points around 40 °C and 60 °C, respectively. By blending or 
copolymerizing PEG with other polymers, the melting point and glass transition 
temperature of the mixture can be adjusted. [67, 69] In the field of biomaterials, this 
characteristic of PEG is also utilized to adjust the mechanical properties of polymers 
applied at body temperature. Ideally, this is done by copolymerization. [70, 71] 
 
As one of the most prevailing biomaterial, PEG has advantageous features resulting 
from its unique chemical structure. Since PEG is hydrophilic and uncharged, it forms 
highly hydrated polymer coils on biomaterial surfaces, which effectively repel 
proteins. For thermodynamic reasons, The process of protein adsorption is extremely 
unfavorable.[72-75] Thus, PEG-modified surfaces can be used to create 
long-circulating micelles or other drug vehicles as well as non-fouling coatings, which 
prevent bacterial growth or cellular adhesion on catheters or medical implants.[76-77] 
This shielding effect can also be used to create inert polymer surfaces, which can later 
be modified with appropriate molecular cues (e.g., peptides or proteins) to obtain 
cell-specific interactions with biomaterials to achieve targeting of particles with 
attached peptide sequences.[78] 
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Other polymers can be modified by incorporated into PEG in multiple ways. First, 
PEG can be attached to one end of the polymer backbone, leading to typical diblock 
copolymers. Triblock copolymers with PEG forming the ends or the middle segment 
can be created to decrease the number of polymer phase segregations in the solid state. 
With many of these multi-block copolymers, an almost perfect mixture of the polymer 
blocks with no detectable segregation can be achieved. Furthermore, multi-block 
copolymers with star-like or comb-like architecture can be synthesized utilizing PEG. 
These structures then provide a way to increase terminal functionalities for subsequent 
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Chapter 3 




All chemicals were purchased from Sigma. They includes DL-propargylglycine 
(PAG), pyridoxal 5′-phosphate,  zinc acetate, trichloroacetic acid, 
N,N-dimethyl-p-phenylenediamine sulfate, hexadecyltrimethylammonium bromide, 
tetramethylbenzidine, hydrogen peroxide, and all common chemicals and 
consumables used in biological labs. Diclofenac and S-diclofenac were the generous 
gift of Dr. P. del Solato (CTG Pharma, Milan, Italy). The rats were purchased from the 
Animal Holding Unit, National University of Singapore.  
 
3.2 Tissue H2S assay 
 
H2S biosynthesis in tissue homogenates was measured essentially as described 
previously. Briefly, liver and skin tissue was homogenized in ice-cold 100 mM 
potassium phosphate buffer (pH 7.4). Optimal w/v ratios of 1:20 (liver), 1:10 (skin) 
were determined from experiments. The assay mixture (500 µl) contained tissue 
homogenate (430 µl), L-cysteine (10 mM; 20 µl), pyridoxal 5′-phosphate (2 mM; 20 
µl), and saline (30 µl) or in some cases PAG (30 µl, 25-2500 µM). Incubation was 
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carried out in tightly sealed eppendorf vials. After incubation (37°C, 30 min), zinc 
acetate (1% w/v, 250 µl) was injected to trap, generated H2S followed by 
trichloroacetic acid (10% w/v, 250 µl) to precipitate protein and thus stop the reaction. 
Subsequently, N,N-dimethyl-p-phenylenediamine sulfate (20µM; 133 µl) in 7.2 M 
HCl was added followed by FeCl3 (30 µM; 133 µl) in 1.2 M HCl, and absorbance 
(670 nm) of aliquots of the resulting solution (300 µl) was determined 15 min 
thereafter using a 96-well microplate reader (Tecan Systems Inc.).  
 
All standards and samples were assayed in duplicate. The H2S concentration of each 
sample was calculated according to a standard curve of NaHS (3.125−250 µM) and 
the enzyme activity was expressed as nanomoles H2S formed per milligram of tissue 
samples. Soluble protein mass in the skin/liver tissue was determined using the 
Bradford assay, (Bio-Rad, Hercules, CA).  
 
3.3 Myeloperoxidase assay 
 
Neutrophil sequestration in skin and liver was quantified by measuring tissue 
myeloperoxidase (MPO) activity as described previously [79]. Briefly, tissue samples 
were washed thoroughly in saline, homogenized in 20 mM phosphate buffer (pH 7.4), 
centrifuged (10,000 g, 10 min, 4°C), and the resulting pellets were re-suspended in 50 
mM phosphate buffer (pH 6.0] containing 0.5% v/v hexadecyltrimethylammonium 
bromide. The suspension was subjected to four cycles of freezing and thawing and 
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further disrupted by sonication (40 s). Samples were then centrifuged (10,000 g, 5 min, 
4°C] and the supernatant used for the MPO assay. The reaction mixture consisted of 
tissue supernatant (50 µl], tetramethylbenzidine (1.6 mM], sodium phosphate buffer 
(80 mM, pH 5.4], and hydrogen peroxide (0.3 mM]. The total incubation volume was 
100 µl. Incubations were conducted at 37°C for 110 s after which the reaction was 
terminated with 0.18 M H2S O4 and absorbance (450 nm] determined. Tissue MPO 
activity was corrected for DNA concentration, which was determined 
spectrofluorimetrically according to a previously published procedure [80]. Results 
are expressed as MPO activity per µg DNA and are shown as percentage increase over 
control. 
 
3.4 Square incisional wound model in rats 
 
Male Sprague-Dawley rats (300-350g) were acclimatized in the Animal Holding Unit 
of this University for a minimum of 7 days and thereafter anaesthetised with a mixture 
of hypnorm (1 ml; Jansen Pharmaceutica, Beerse, Belgium) containing fentanyl 
(0.315 mg), fluanisone (10 mg) and 1 ml of midazolam (Roche, Basel, Switzerland (5 
ml of dormicum in 2 ml water)). Animals were injected with 0.6 ml 100 g-1 (i.p.) of 
this mixture for induction and 0.1 ml 100g-1 (i.p.) for maintenance if required. The 
hair on the dorsum of each animal was removed using an electric shaver and a full 
thickness square wound (15 mm x 15 mm) was made on the dorsum by excising the 
skin within the confines of the square down to the level of the panniculus carnosus. 
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The dissection was performed using a size 15 blade and care was taken not to contuse 
the borders. Thereafter, animals were allowed to recover from the anesthetic, placed in 
individual cages and allowed access to food and water. The wound was left to heal for 
10 days without any dressing being applied. The outline of the wound was measured 
every 24 h at 2pm in the afternoon. To measure the wounds, animals were held 
immobile with the head covered and both the length (L) and the breadth (B) of the 
wound was measured so as to calculate the total wound area (i.e. L x B).  A 
mathematic model was applied to determine the time to half wound healing. In the 
exponential phase starting from Day 3, the change in area per change in time is a 
function of the remaining area. Such a relationship, in which the rate of change of area 
is a function of the area itself, is a first-order differential equation whose general 
solution is area =A0+ B x [e-k x t] where A0 represents the area remaining after 
contraction is completed, which is zero in our experiment situation. B is the area that 
will undergo contraction. K is the decay constant. [12] The rate of wound contraction, 
k, was obtained by plotting the log of area versus time. The slope of each regression 
line is taken as the co-efficient of wound contraction [k] for each animal. The k value 
of each wound is indicative of the rate of wound contraction. To quantitatively 
analyze the contraction period, a linear curve-fitting algorithm was used to calculate 
the k value. The half-time for wound healing (t1/2) was also calculated. 
 
In the experiments, 36 male Sprague-Dawley rats (300-350g) were divided into 3 
groups (n=12), administered with saline (0.9% w/v NaCl, x ml/kg, i.p, Group A), 
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10mg/kg weight DL-propargylglycine (PAG, i.p., Group B), and 100mg/kg weight 
DL-propargylglycine (PAG, i.p, Group C) respectively 2h prior to surgical wounding. 
In the diclofenac experiments, 36 male Sprague-Dawley rats (300-350g) were divided 
into 3 groups (n=12), administered with saline (0.9% w/v NaCl, 100ml/kg, i.p, Group 
A), Diclofenac sodium(100μmole/kg, i.p, Group Ac-Na), and S-diclofenac(100μ
mole/kg, i.p, Group Ac-S) respectively 2h prior to surgical wounding. Another 12 rats 
were used as controls not subjected to wounding or drug administration.  
 
All animals were thereafter killed 5 or 10 days after surgery by cervical dislocation，
blood (approx. 2ml) was directly removed from heart and skin samples (approx. 
200mg) were taken from both the immediate wound area, a small amount of liver 
(approx. 2g)  were also collected for subsequent biochemical experiments as 
described below. All the samples are stored in -80 degree refrigerator at school to be 
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z Fig.3.1 square incisional m
 
3.5 Preparation of Hydrogel 
 
ns used in this study was PAG 100 
g, sodium carboxymethylcellulose (NaCMC) 3 g, propylene glycol ((PEG, 8 arms, 
W g 3% (w/w) 
aCMC in water for a period of 2 h. PAG was dissolved in propylene glycol and the 
CMC dispersion under continuous stirring. The same 
odel and the large view of wounded area. 
 
The composition of the PAG-PEG gel formulatio
m
M =20,000) 20 g, water up to 100 g. Gels were prepared by dispersin
N
solution was added gently to Na
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method was employed for the preparation of gels with sodium chloride as the control. 
nes for the care and use of 
boratory animals (NIH Pub.No. 85-23 Rev. 1985) were observed. 
toluene and then 
mbedded in paraffin wax. 4um sections were thereafter cut and stained with 
H&E). After deparaffinization and rehydration, sections were 
en washed, mounted and visualized with light microscopy (Olympus BX51) at 
The mixture was poured into a glass slide and the reaction was allowed to proceed for 
24 h at room temperature until the water was completely vaporized and a layer of 
adhesive film was left in the glass slide. The glass slides were placed under UV light 
for five minutes on each side for sterilization purposes. 
 
The dry weight of the PEG-PAG gels was recorded. The amount of gel formed from 
the initial precursor gel solution was recorded as gel/sol percent (i.e. % gel=weight of 
dry gel/weight of dry gel before washing ×100). The film was cut into the shape 
fitting to the wound and directly placed on the wound at designed place on the 
dorsum.. National Institutes of Health (NIH) guideli
la
 
3.6 Histological study 
 
Liver and skin segments (~100 mg) were fixed in 10% v/v phosphate-buffered 
formalin (pH 7.4) for 24 h. Tissue were then dehydrated in a ascending series of 
alcohol (50%, 70%, 80%, 90%, 95%, 100% v/v), transferred to 
e
hematoxylin and eosin (
th
400X magnification. 
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Data are presented as mean ± SE. Statistical significance was analyzed by variance 
(ANOVA), a Tukey test was applied when necessary for comparisons. A value of P< 
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Chapter 4 
H2S synthesizing activity in wounded and normal rats 
.1 Preliminary study to determine H2S synthesizing activity in control rats 
ithout drug administration 
In preliminary experiments, we fou average wound healing for square 
incisional mod s to achieve 
0% recovery. [Fig.4.1]  
ound contraction was expressed as the fraction of 
riginal area over time and divided into three phases: a pre-exponential or plateau 
 to day 2, a very slow decrease in wound area follows the 





nd that the 
el (15 mm x 15 mm) in healthy rats usually take 10 day
8
 
Following skin tissue loss, w
o
phase, an exponential phase during which the wound contracts in an exponential 
fashion, and a post-exponential phase. In fig 4.1, during the pre-exponential phase or 
plateau phase from day 0
c
wounded area diminishes, first rapidly and then more slowly. From day 3 to day 9, the 
change in area per change in time is a function of the remaining area. Such a 
relationship, in which the rate of change of area is a function of the area itself, is a 
first-order differential equation whose general solution is an exponential of the form: 
Area =A0+B x e-kt (A0 represents the area remaining after contraction is completed, in 
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0 = 0; B is the area after surgery that will undergo contraction; k is 
the decay constant, which will be called the contraction-rate constant; and t is any 
given time).   
 
From the literature, the behavior of all experimentally induced wounds, regardless of 







 Fig. 4.1 The wound contraction curve of normal skin wound healing (Mean value 
of wound area (in percentage) for each day after wounding± SEM, n=6, p<0.05) 
ay 5 and 10 were chosen as appropriate time points to examine tissue H2S 
ynthesizing activity and inflammation in the exponential and post-exponential phase 
 the wound healing process. H2S synthesizing activities in liver and skin for both 
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wounded and non-wounded animals were examined. [Fig.4.2] 
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ent 
he graph showed that H2S synthesizing activity in skin for healthy animal was 
ignificantly lower (0.14±0.01nmoles/mg soluble protein/min, n=6, p<0.05) than the 
ounded animal. On the 5th day after wounding in vehicle-injected animals, H2S 
ynthesizing activity in wounded skin was significantly increased by several folds 
recovery, 


















(p<0.05, n=6 c.f. non-wounded animal skin). While on the 10th day near 
H
[Fig 4.2]  
 
 
4.2 The impact of PAG administration on skin H2S synthesizing activity in rats   
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From the above experiments, we knew that H2S synthesizing activity in rat skin is 
increased after wounding. We suspect that this increase is positively related to the 
flammation associated with wound healing.  
roduction by administering PAG, a cystathionine-γ-lyase inhibitor, was possible in 
me surface. [82] In the experiment, 




Therefore we decided to investigate whether the inhibition of endogenous H2S 
p
this model. PAG was chosen since it has been reported by Abeles and Walsh [81] to 
inhibit cystathionine-γ-lyase in an irreversible, covalent manner presumably via the 
generation of an allene intermediate on the enzy
w
expected, a significant dose-dependent decrease in H2S synthesizing activity of 
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• Fig.4.3 Time-and dose-dependent effects of PAG pretreatment on H2S 
synthesizing activity in skin tissue. Skin H2S synthesizing activities in 
wounded animals with low and high doses of drug treatment are shown. Initial: 
healthy animal sample without wounding; Control: rats with vehicle 
pretreatment after wounding; GrpB: rats pretreated with 10mg/kg weight PAG 
2 h before wounding. GrpC: rats pretreated with 100mg/kg weight PAG 2 h 
before wounding. Results are shown as mean±SE, n=6, +P<0.05 over null 
animal skin samples, *P<0.05 over vehicle administered control)  
 
 
4.3 The impact of PAG administration on liver H2S synthesizing activity in 
animals 
 
H2S synthesizing activity in the liver was regarded as a positive control for the PAG 
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administration, for the liver was experimentally proved to be the most sensitive to 
PAG treatment. [Fig.4.4] liver samples from animals in group B & C on the 5th day 
exhibited a similar pattern as the H2S synthesizing activities in skin tissue. On the day 
5 after wounding, the H2S synthesizing activity of animals pretreated with PAG 
(10mg/kg) was reduced, this inhibiting effect was greater in animals treated with 









• Fig.4.4 Time- and dose-dependent effects of PAG pretreatment on H2S 
synthesizing activity of liver tissue are shown. Initial: healthy animal sample 
without wounding; Control: rats with vehicle pretreatment after wounding; 
GrpB: rats pretreated with 10mg/kg weight PAG 2 h before wounding. GrpC: 
rats pretreated with 100mg/kg weight PAG 2 h before wounding. Results are 
shown as mean±SE, n=6, +P<0.05 over null animal skin samples, *P<0.05 
over vehicle administered control)  
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4.4 The impact of PAG administration on MPO activity in wound healing 
 
We measured the fold increase in MPO activity in control animals after wounding. In 
vehicle pretreated animals, surgery induced wounding caused inflammation, indicated 
by a significant elevation in skin MPO activity on day 5, while on the day 10 after 







• Fig .4.5 Time-dependent effects of wound healing on MPO activity in skin 
samples with vehicle treatment because of the inflammation. Assume 100% 
MPO activity before wounding, Results are shown as mean±SE, n=6, *P<0.05 
c.f. Null control. MPO activity was measured on day 5 and day 10. 
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In rats pretreated with PAG, PAG pretreatment reduced skin MPO activity induced by 
the inflammation on day 5 after wounding. [Fig 4.6] This reducing effect of PAG 






• Fig.4.6. MPO activity with different doses of PAG administration in wound 
healing on day 5 after wounding. (Null: healthy animal sample without 
wounding; Control: rats with vehicle pretreatment after wounding; GrpB: rats 
pretreated with 10mg/kg weight PAG 2 h before wounding. GrpC: rats 
pretreated with 100mg/kg weight PAG 2 h before wounding. Results are 
shown as mean±SE, n=6, +P<0.05 over healthy animal skin samples, *P<0.05 
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The effects of PAG pre-treatment on wound healing 
 
5.1 The effect of PAG treatment to accelerate wound healing 
 
Following the removal of skin, wound size starts to shrink due to the inward 
contraction of the wound edges from day 2. To measure wound healing, the remaining 
skin area after contraction was expressed as the percentage of the original area over 
time. The fraction of the original area over time (3-9 days) for animals administered 
with low and high doses of PAG (10 and 100mg/kg) as well as control animals 
administered vehicle are shown in Fig.5.1. From this figure we could clearly see the 
contraction pattern of different groups of rats. 
 
                                           - 52 - 












• Fig. 5.1 Wound contractions were plotted as the fraction of original area after 
wounding. The original wounded area at day 0 is defined as 100 percent 
original area; the areas at day 3, 6 and9 are calculated as the percentages of the 
original area for each group of rats. The data of 6th day suggests the largest 
difference among groups with different dose pretreatment (Initial: 100% 
original area; Control: rats with vehicle pretreatment 2 h before wounding; 
GrpB: rats pretreated with 10mg/kg weight PAG 2 h before wounding. GrpC: 
rats pretreated with 100mg/kg weight PAG 2 h before wounding, n=6, +P<0.05, 
c.f vehicle administered controls)  
 
 
Based on the graph, the half-time for wound healing (the time required for the wound 
reduced to 50% of its original area) were calculated as 6.47, 5.30 and 4.40 days for 
the vehicle group, PAG (10mg/kg) and PAG (100mg/kg) respectively. From the data 
we can tell that the treatment of animals with a low dose of PAG accelerated wound 
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healing (n=6, p<0.05). Furthermore, the higher dose of PAG (100mg/kg) was 
significantly more effective than the lower dose (10mg/kg). 
 
5.2 The effects of PAG treatment on skin histology 
 
Microscopic examination revealed that the epithelium of the injured skin became 
thinner when compared with control skin [Fig.5.2]. In addition, fibrosis and 
disorganization of fibroblast-like cell layers in dermis were observed in the wounds of 
the rats pretreated with low dose of PAG (10mg/kg), In the higher dose treated group 
of rats (100mg/kg), fibrosis was more severe, the skin tissue shows a more dense 
appearance, and the boundary between different layers was more blurred [Fig.5.2]. 
Histological study also revealed that fibroblast-like cells aggregated in the wounded 
area. [Fig.5.3] 
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• Fig. 5.2 Hematoxylin and eosin stained sections of skin samples from control, 
GrpB & GrpC. [A] and [B] show the cutaneous cell structure of the rats from 
control group at day 5 and day 10 respectively [C] and [D] show the sections 
from GrpB animals at day 5 and day 10 respectively; [E] and [F] showed the 
pictures from GrpC animals at day 5 and day 10 respectively. [G] & [H] were 
in large view of the 400 pixels x 400 pixels squares taken from [E] & [F]. 
[Control: animal skin samples with vehicle treatment after wounding; GrpB: 
rats with 10mg/kg weight PAG pretreated 2 h before wounding. GrpC: rats 
with 100mg/kg weight PAG pretreated 2 h before wounding] 
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• Fig.5.3 the numbers of fibroblast-like cells from each group of animals per 
400 pixels x 400 pixels square were counted by a hemocytometer. Null: null 
animal sample without wounding; Control: rats with vehicle treatment; GrpB: 
rats with 10mg/kg weight PAG pretreated 2 h before wounding. GrpC: rats 
with 100mg/kg weight PAG pretreated 2 h before wounding. results are 
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Chapter 6 
The effect of a H2S donor and PAG incorporated hydrogel on wound healing 
  
6.1 The effects of S-diclofenac (H2S donor) on wound healing 
 
We have demonstrated that the PAG administration not only effectively and 
dose-dependently reduced H2S synthesizing activity in the skin, as well as in the liver, 
but also down-regulated the inflammation which occurs in the skin tissue and 
accelerates wound healing. In this part of thesis project, we used a new compound, 
S-diclofenac (H2S donor) able to slowly release H2S in the animal after intraperitoneal 
injection, to further investigate the role of H2S in the wound healing.  
 
From the literature, Diclofenac sodium without the H2S releasing factor was 
demonstrated to effectively accelerate the wound healing for its anti-inflammatory 
characteristics which are shared by all non-steroidal anti-inflammatory drugs 
(NSAIDs). We demonstrated that the S-diclofenac treated animals exhibited a slower 
wound contraction after wounding compared to the diclofenac sodium treated animals. 
[Fig. 6.2] The same mathematical model used in PAG experiments was applied on 
data from S-diclofenac and controls to calculate the half-time for healing. The 
half-time for healing in animals pretreated with S-diclofenac, diclofenac sodium and 
saline was 6.81, 4.52 and 6.47 days respectively(n=6, p<0.05). Thus, the unfavorable 
effect of slow releasing H2S of S-diclofenac in wound healing in the rats was noticed 
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in this study. In other words, diclofenac promoted wound healing which effect was not 











• Fig. 6.2 Wound contractions plotted as the fraction of original area after 
wounding. The original wounded area at day 0 is defined as 100 percent 
original area; the areas at day 3, 6 and9 are calculated as the percentage of the 
original area for each group of rats. The data of 6th day suggests the largest 
difference among groups with different dose pretreatment (Initial: 100% 
original area; Control: rats with vehicle pretreatment 2 h before wounding; 
Ac-Na: rats pretreated with 100μmole/kg Diclofenac Sodium 2 h before 
wounding. Ac-S: rats pretreated with 100μmole/kg S-diclofenac 2 h before 
wounding, n=6, +P<0.05, c.f. vehicle administered controls)  
 
6.2 Evaluation of PAG incorporated hydrogel wound dressing 
 
The transparent gel was prepared before the surgery. The polyethylene glycol (PEG) 
gel was sufficiently firm to be handled with forceps and the shape of the gel did not 
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change even when the gel was shaken. The gel positioned at the wound site 
maintained its three-dimensional mass rather than spreading. In vivo studies showed 
that it takes a few seconds for the gel to be steadily attached to the wounds at room 
temperature and would not be shaken off from the rat’s dorsum. The integrity of the 
gel persisted for more than 6 days when the gel was partially degraded and the 
remnant was removed on day 12 after surgery. 
 
Using the PEG gel in the absence of PAG, the half time for healing was reduced from 
6.47 days to 4.93 days largely due to the protection from the invasion of outside 
agents and maintenance of a moisture environment provided by the hydrogel. (n=6, 
p<0.05) [52] With PAG (10mg/kg) contained within the PEG gel, animals should 
achieved a faster wound repair process because of the anti-inflammatory effect of 
PAG. Although not significant as we expected, the half time for healing in PEG-PAG 
treated animals was further more reduced to 4.35 days compared to the blank gel 
controls. (n=6, p<0.1) The precise role played by H2S in this combination hydrogel of 
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Chapter 7  
Discussion 
 
7.1 H2S synthesizing activity in wound healing 
 
H2S synthesizing activity (from added L-cysteine) was detected in skin sample from 
control rats. Following wounding, skin H2S synthesizing activity sharply increased 
and gradually restored to the normal low level throughout the wound repair process. 
Although there is little information in the literature concerning the possible role of 
H2S in this condition, previous work has suggested that the up-regulation of CSE 
activity is responsible for the overproduction of endogenous H2S and augmented 
inflammation in some other animal inflammation models (e.g. induced endotoxic 
shock [17]).  
 
The present study highlighted a role for H2S in the inflammation stage of wound 
healing. H2S synthesizing activity was inhibited by PAG, and inflammation was 
measured by examining MPO activities that indicate the influx of neutrophils. 
Historically, Bhatia, et al (2005) first reported the potential pro-inflammatory action 
of endogenously generated H2S in acute pancreatitis and associated lung injury. 
Similar experiments showed that H2S administration (by injection of NaHS – a 
water-soluble H2S donor drug in rats) resulted in augmented liver and kidney MPO 
activity and additionally caused inflammatory damage in the lung but not liver. 
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Furthermore, the inhibition of endogenous H2S synthesizing activity contributes to a 
less severe tissue damage and lower MPO activity in acute pancreatitis and associated 
lung injury [27]. Interestingly, similar inflammation of the airways has also been 
noted in man following accidental environmental exposure to H2S [15, 30]. It has 
been speculated that the pro-inflammatory effect of H2S may related to its vasodilator 
activity. [30] As such, we demonstrated in out experiment that H2S may exhibited a 
similar pro-inflammatory effect with impacts on skin wounding and that inhibition of 
H2S synthesis may therefore resulted in an anti-inflammatory effect and thus provided 
a possible new approach to treating the inflammation and thus to improve wound 
healing.    
 
The critical role of CSE in the enhanced H2S formation that we detected in these H2S 
assay is further highlighted by experiments in which endogenous H2S biosynthesis 
was manipulated using PAG. The present experiments show that PAG produces a 
dose-dependent inhibition of H2S synthesizing activity in skin adjacent to the surgical 
wound (assessed by a decrease of H2S production from added L-cysteine ex vivo). We 
also find that PAG pre-treatment significantly shortened the wound repair time and 
accelerated wound contraction in the rat model (assessed by the examination of 
residue areas after wound contraction among different groups). The reduction of 
neutrophil infiltration indicated by MPO activity after PAG pretreatment provides a 
possible protection against tissue damage therefore accelerate wound healing process. 
The present study also indicates that PAG pre-treatment lead to slight fibrosis in the 
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process of wound healing, though the surfaces of the healed skin at day 12 from drug 
treated animals are smooth with little scar or keloid left when compared with control 
(vehicle-treated animals). However, the precise role of H2S in wound healing and 
inflammation and fibrosis observed in PAG pretreated rats is still not clear and 
requires further investigation. 
 
Although the roles of H2S in inflammation and wound healing remain unclear, the 
possibility of cross-talk with nitric oxide (NO) has been already suggested by 
previous research, [36] perhaps, can be considered. Both of the gases are synthesized 
in the blood vessels. [16] Conversion of L-cysteine to H2S in rat aortic tissue is 
enhanced by treatment with sodium nitroprusside (SNP), an NO donor. SNP also 
increases the expression of CSE in cultured vascular smooth muscle cells [81]. One 
latest study has showed that H2S enhances NO production and iNOS expression by 
potentiating IL-1 induced NF-kB activation through a mechanism involving ERK1/2 
signaling cascade in rat vascular smooth muscle cells [82]. NO provided by 
nitroflurbiprofen reduces the biosynthesis of H2S in LPS induced endotoxemia, which 
may be due to the inhibition of transduction via the NF-kB pathway [81]. Some author 
also suggested that the principal physiological role of H2S, released from the 
vasculature, may be to regulate local concentrations of NO rather than to dilate blood 
vessels directly. [82] Previous work also showed that inhibition of nitric oxide 
synthase (e.g. nNOS (early phase) and iNOS (late phase) ) at the site of inflammation 
was anti-inflammatory. [34] So we suggest that NO and H2S may work together to 
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promote inflammation in this wound healing model.  
 
Since inhibition of endogenous H2S biosynthesis might offer some protection towards 
the inflammation damage caused by skin wounding, we were interested in whether 
H2S itself provoked an inflammatory reaction in wound healing. For this purpose, we 
applied the H2S donor, S-diclofenac, to investigate wound healing. The present work 
revealed that diclofenac sodium is effective in reducing the half-time for wound 
healing most probably because of its anti-inflammatory (i.e. COX inhibitor) function 
group of diclofenac. However, the ester form of diclofenac that gradually released 
H2S to the wounds (S-diclofenac) exhibited a significantly longer healing process. 
Combining with the data of MPO from the rats with PAG pretreatment (H2S 
synthesizing inhibitor), the higher concentration of H2S may contribute to the 
prolonged wound healing possibly by promoting inflammation. However, the 
molecular mechanism of the interaction between high concentration of H2S / 
S-diclofenac and cells still remains to be investigated.  
 
7.2 The application of PAG incorporated hydrogel dressing 
 
In the above experiments, the drug (PAG) was proved effective in reducing 
inflammation after the intra-peritoneal injection. Therapeutically, there is another 
preferred route of drug administration, hydrogel dressings able to promote wound 
healing by moisture retention thereby maintaining a homeostatic environment. Thus, 
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the combination of PAG with hydrogel dressing should be a better approach to reduce 
inflammation response in the treatment of skin wounds. The studies tried to use 
PEG as the material for hydrogel dressings and succeeded in obtaining an elastic, 
well-affixable and film-moldable material. The film developed was thin and easily 
prepared for possible clinical applications. Moreover, PEG gel sheets provide stable 
preservation of PAG while release it into the wound after PEG undergo degradation. 
Compared to the gel without PAG, PEG/PAG film resulted in a significantly 
accelerated wound healing. 
 
To conclude, the data reported here shows that inhibiting H2S synthesis in wounded 
rat skin dose-dependently help suppressing inflammation and shorten the time for 
wound repair. Therefore, our results suggest that H2S plays a proinflammatory role in 
wound healing possibly by participating in NO/ H2S crosstalk and/or the NF-kB 
pathway, the result was further confirmed by the fact that the administration of H2S 
donor drug S-diclofenac led to an elongated wound healing. The precise molecular 
mechanism of the role of H2S as an inflammatory mediator will be the subject of 
future studies. After that, the present study also investigate into the application of 
PAG-enclosed polyethylene glycol gel on square full-thickness wounds that accelerate 
wound repair, thereby suggesting that PAG-enclosed hydrogel may have therapeutical 
potential for the dressing of various skin wounds including surgical removal of skin 
and burns. 
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